SPTLC2 and neurodegenerative disease: Alterations of the SPT activity caused by mutations of either SPTLC1 or SPTLC2 gene are linked to neurodegenerative diseases such as hereditary sensory and autonomic neuropathy type I (HSAN1) in human (15, 16, 17, 18).